These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13198660)

  • 1. [Protein deficiency in pathogenesis of ascites in liver cirrhosis].
    CANELLA C
    Arcisp S Anna Ferrara; 1954; 7(1):7-27. PubMed ID: 13198660
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of ascites in liver cirrhosis.
    Buhac I
    Gastroenterology; 1980 Oct; 79(4):774-6. PubMed ID: 7409398
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the pathogenesis of ascites and hepatic coma after paracentesis in cirrhosis of the liver].
    ZANNINI L
    Minerva Med; 1961 Oct; 52():3487-92. PubMed ID: 14009820
    [No Abstract]   [Full Text] [Related]  

  • 4. [Auto-reproteinization by infusion of ascitic fluid subjected to concentration by heating].
    MICHON P; KLING C
    Rev Med Nancy; 1955 Feb 1-15; 80():113-5. PubMed ID: 14372668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cirrhotic ascites; pathogenesis and therapeutic study].
    CACHERA R; DARNIS F
    Bull Med; 1954 Jan; 68(1):3-6. PubMed ID: 13141031
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathogenesis of ascites and a consideration of its treatment.
    MADDEN JL; LORE JM; GEROLD FP; RAVID JM
    Surg Gynecol Obstet; 1954 Oct; 99(4):385-91. PubMed ID: 13205408
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in the pathogenesis and management of cirrhotic ascites.
    CANTER JW; ROSENTHAL WS; BARONOFSKY ID
    N Y State J Med; 1961 Mar; 61():913-9. PubMed ID: 13690508
    [No Abstract]   [Full Text] [Related]  

  • 9. PERMANENT DRAINAGE OF ASCITES. A CLINICAL STUDY OF ADVANCED CIRRHOSIS OF THE LIVER.
    SEIRO V; AUTIO L; TURUNEN M
    Acta Chir Scand; 1964; 127():88-92. PubMed ID: 14104710
    [No Abstract]   [Full Text] [Related]  

  • 10. [New views on the origin and therapy of ascites in liver cirrhosis].
    CANELLA C
    Minerva Med; 1957 Nov; 48(90):3747-52. PubMed ID: 13503859
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of ascites and hepatic hydrothorax.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Gastroenterol; 2007; 21(1):55-75. PubMed ID: 17223497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low salt concentrated human albumin in therapy of ascites due to liver cirrhosis].
    SCHOUTEN J
    Ned Tijdschr Geneeskd; 1953 Nov; 97(45):2919-25. PubMed ID: 13144807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of the formation of ascites in patients with cirrhosis of the liver. II. General factors].
    RIVERA A; DIES F
    Rev Invest Clin; 1961; 13():157-90. PubMed ID: 14038706
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver cirrhosis, ascites, and hyperfibrinolysis.
    Piscaglia F; Donati G; Giannini R; Bolondi L
    Am J Gastroenterol; 2001 Nov; 96(11):3222. PubMed ID: 11721792
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of ascites due to cirrhosis of the liver controlled by ionexchange resins.
    GRANT CW
    Practitioner; 1957 Jul; 179(1069):75-6. PubMed ID: 13453098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First results obtained with the use of the spirolactone SC-9420 (aldactone) in the treatment of ascites caused by liver cirrhosis].
    DE FILIPPIS V; MARSICO F; PEDICINI S
    Riforma Med; 1960 Dec; 74():1516-20. PubMed ID: 13720490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
    RIVERA A; SEPULVEDA B; LANDA L; CHAGOYA L
    Rev Med Chil; 1961 Oct; 89():843-6. PubMed ID: 14038707
    [No Abstract]   [Full Text] [Related]  

  • 20. [Signs of ariboflavinosis during hepatic cirrhosis; presence of riboflavin in ascites].
    BENEDETTI A
    Acta Vitaminol; 1953 Dec; 7(6):260-4. PubMed ID: 13124124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.